Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

Journal of Hepatology · 2012 · 2.9K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Chronic hepatitis B: Update 2009 #

Anna S. Lok, Brian J. McMahon · Hepatology · 2009 · 2.8K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

Yun‐Fan Liaw, Joseph J.�Y. Sung, Wan Cheng Chow et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Ting‐Tsung Chang, Robert G. Gish, Robert de Man et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10